Early palliative care for advanced soft tissue sarcoma
Part of Cancer clinical trials.
This study tests whether adding palliative care early on to standard cancer treatment improves quality of life for people newly diagnosed with advanced or metastatic soft tissue sarcoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic soft tissue sarcoma that cannot be cured.
- You are 18 years or older.
- You have not yet received any chemotherapy or other systemic treatment for your advanced sarcoma.
- You are able to take care of yourself (ECOG performance status 0-2).
- Your doctor expects you to live more than 6 months.
- You are willing and able to fill out questionnaires about your health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This study tests if getting a psychiatric consultation soon after a sarcoma diagnosis can improve mental health and quality of life. If you have a new sarcoma and need surgery at MSK, you may be able to join.
This study tests whether having a palliative care specialist meet with patients early during an unplanned hospital stay improves their care and quality of life. Palliative care focuses on comfort and symptom management, and this trial aims to see if adding it to usual treatment helps.
This study tests whether adding early palliative care from a specialist improves well-being for people starting treatment for advanced non-small cell lung cancer. It compares standard cancer care alone to standard care plus early palliative care.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.